Mid-Cap

Fall in Greencross and Primary Healthcare

June 08, 2016 | Team Kalkine
Fall in Greencross and Primary Healthcare

 
Greencross Limited


GXL Details

  • Increase in Credit Suisse voting power: Greencross Limited (ASX: GXL) stock plunged over 7.5% on June 07, 2016 impacted by the group’s update of Credit Suisse increased voting power. As per the reports filed by GXL, Credit Suisse have been gradually increasing its stake in GXL since February and currently has 14.577 million shares and 12.7% voting power. The group is a clear market leader as compared to its immediate competitors and intends to further boost its network with more than 350 stores and 350 vet clinics. GXL is also aiming to be a leading player in online platform as well as is seeking to enhance sales of private label and exclusive products. GXL is also offering a one stop shop for products, veterinary care, grooming, DIY dogwash and specialty medical. The group is already cross selling via its existing portfolio.
  • Recommendation: We maintain our “Hold” recommendation on GXL at the current price of $7.34

Leading specialty pet retailer and veterinary group in Australasia (Source: Company Reports)
 
Primary Health Care Ltd


PRY Details
  • Strategic update: Primary Health Care Limited (ASX: PRY) stock surged over 0.77% on June 07, 2016 driven by the group’s strategic update today. For medical centers private billing, the group is focusing on diversification of revenue, launching new brands and intends to offer a differentiated proposition by leveraging its scale. The group is focusing to improve efficiencies for its mature pathology business. PRY also boosted its capital position by selling Barangaroo for $40m in March 2016 and Medical Director for $156 million sale in May 2016. PRY even cut its net debt position to over $900 million (pre-tax) from capital recycling as of first half of 2016. On the other hand, the Government has decreased its Bulk billing incentive which would continue to pose pressure on the stock in the coming months.
  • Recommendation: We give an “Expensive” recommendation on PRY at the current price of $3.99


Disclaimer
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376).The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd currently hold positions in:  BHP, BKY, KCN, PDN, and RIO. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.